Clinical trial
Nitric Oxide Supplementation to the Extracorporeal Circulation Line as a Method of Nephroprotection in Cardiac Surgery
NCT03527381 is registered in ClinicalTrials.gov with Nikolay Kamenshchikov as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nitric Oxide Supplementation to the Extracorporeal Circulation Line as a Method of Nephroprotection in Cardiac Surgery
- Lead sponsor
- Nikolay Kamenshchikov
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 1, 2015
- Completion date
- April 14, 2017
- Enrollment
- 96 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.